An	O
erythroid	B-DNA
specific	I-DNA
enhancer	I-DNA
upstream	O
to	O
the	O
gene	O
encoding	O
the	O
cell-type	B-protein
specific	I-protein
transcription	I-protein
factor	I-protein
GATA-1	B-protein
.	O

The	O
transcription	B-protein
factor	I-protein
GATA-1	B-protein
is	O
expressed	O
in	O
a	O
subset	O
of	O
hemopoietic	B-cell_type
cells	I-cell_type
,	O
where	O
it	O
mediates	O
the	O
cell-type	O
specific	O
expression	O
of	O
several	O
genes	O
.	O

We	O
have	O
cloned	O
the	O
mouse	O
and	O
human	O
GATA-1	B-DNA
genes	I-DNA
.	O

A	O
region	O
upstream	O
to	O
the	O
first	O
exon	O
,	O
and	O
highly	O
conserved	O
between	O
mouse	O
and	O
man	O
,	O
acts	O
as	O
an	O
erythroid	O
specific	O
enhancer	O
in	O
transient	O
assays	O
,	O
if	O
linked	O
to	O
the	O
GATA-1	B-protein
or	O
to	O
the	O
SV40	O
promoter	O
.	O

The	O
activity	O
of	O
the	O
enhancer	O
is	O
almost	O
completely	O
dependent	O
on	O
the	O
integrity	O
of	O
a	O
dimeric	B-DNA
GATA-1	I-DNA
binding	I-DNA
site	I-DNA
.	O

©	NULL
1991	NULL
Oxford	NULL
University	NULL
Press	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

19	NULL
5285-5291	NULL
An	NULL
erythroid	NULL
specific	NULL
enhancer	NULL
upstream	NULL
to	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
cell-type	NULL
specific	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
Silvia	NULL
Nicolis	NULL
,	NULL
Chiara	NULL
Bertini	NULL
,	NULL
Antonella	NULL
Ronchi	NULL
,	NULL
Stefania	NULL
Crotta	NULL
,	NULL
Luisa	NULL
Lanfranco	NULL
'	NULL
,	NULL
Emanuela	NULL
Moroni	NULL
``	NULL
,	NULL
Barbara	NULL
Giglioni®	NULL
and	NULL
Sergio	NULL
Ottolenghi*	NULL
Dipartimento	NULL
di	NULL
Genetica	NULL
e	NULL
di	NULL
Biologia	NULL
dei	NULL
Microrganismi	NULL
,	NULL
Universita	NULL
di	NULL
Milano	NULL
,	NULL
'Dipartimento	NULL
di	NULL
Genetica	NULL
,	NULL
Biologia	NULL
e	NULL
Chimica	NULL
Medica	NULL
,	NULL
Universita	NULL
di	NULL
Torino	NULL
and	NULL
``	NULL
Centro	NULL
sullo	NULL
Studio	NULL
della	NULL
Patologia	NULL
Cellulare	NULL
del	NULL
CNR	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
Received	NULL
July	NULL
4	NULL
,	NULL
1991	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
September	NULL
6	NULL
,	NULL
1991	NULL
EMBL	NULL
accession	NULL
nos	NULL
X56854	NULL
and	NULL
X60824	NULL
ABSTRACT	NULL
The	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
hemopoietic	NULL
cells	NULL
,	NULL
where	NULL
it	NULL
mediates	NULL
the	NULL
cell-type	NULL
specific	NULL
expression	NULL
of	NULL
several	NULL
genes	NULL
.	NULL

We	NULL
have	NULL
cloned	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
GATA-1	NULL
genes	NULL
.	NULL

A	NULL
region	NULL
upstream	NULL
to	NULL
the	NULL
first	NULL
exon	NULL
,	NULL
and	NULL
highly	NULL
conserved	NULL
between	NULL
mouse	NULL
and	NULL
man	NULL
,	NULL
acts	NULL
as	NULL
an	NULL
erythroid	NULL
specific	NULL
enhancer	NULL
in	NULL
transient	NULL
assays	NULL
,	NULL
if	NULL
linked	NULL
to	NULL
the	NULL
GATA-1	NULL
or	NULL
to	NULL
the	NULL
SV40	NULL
promoter	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
is	NULL
almost	NULL
completely	NULL
dependent	NULL
on	NULL
the	NULL
integrity	NULL
of	NULL
a	NULL
dimeric	NULL
GATA-1	NULL
binding	NULL
site	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
expression	NULL
of	NULL
proteins	NULL
characteristic	NULL
of	NULL
differentiated	NULL
cells	NULL
is	NULL
thought	NULL
to	NULL
require	NULL
subsets	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
are	NULL
either	NULL
exclusively	NULL
present	NULL
or	NULL
selectively	NULL
enriched	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Recent	NULL
studies	NULL
identified	NULL
in	NULL
mammalian	NULL
erythroid	NULL
cells	NULL
at	NULL
least	NULL
two	NULL
such	NULL
factors	NULL
:	NULL
GATA-1	NULL
(	NULL
1-4	NULL
)	NULL
and	NULL
NFE2	NULL
(	NULL
5	NULL
)	NULL
.	NULL

These	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
several	NULL
major	NULL
genes	NULL
expressed	NULL
in	NULL
erythroid	NULL
and/or	NULL
megakaryocytic	NULL
cells	NULL
,	NULL
including	NULL
globin	NULL
,	NULL
porphobilinogen	NULL
deaminase	NULL
and	NULL
erythropoietin	NULL
receptor	NULL
(	NULL
6-10	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
GATA-1	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
development	NULL
of	NULL
the	NULL
erythropoietic	NULL
system	NULL
(	NULL
11	NULL
)	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
restricted	NULL
expression	NULL
of	NULL
GATA-1	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
the	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
GATA-1	NULL
gene	NULL
.	NULL

Here	NULL
we	NULL
describe	NULL
an	NULL
upstream	NULL
erythroid	NULL
specific	NULL
enhancer	NULL
,	NULL
that	NULL
binds	NULL
strongly	NULL
to	NULL
GATA-1	NULL
itself	NULL
,	NULL
and	NULL
whose	NULL
activity	NULL
is	NULL
almost	NULL
entirely	NULL
dependent	NULL
on	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Mouse	NULL
and	NULL
human	NULL
DNA	NULL
library	NULL
screening	NULL
A	NULL
library	NULL
of	NULL
partially	NULL
digested	NULL
Mbol	NULL
fragments	NULL
from	NULL
BALB/C	NULL
mouse	NULL
DNA	NULL
inserted	NULL
in	NULL
phage	NULL
EMBL3	NULL
(	NULL
12	NULL
)	NULL
was	NULL
screened	NULL
by	NULL
standard	NULL
methods	NULL
using	NULL
a	NULL
cDNA	NULL
fragment	NULL
from	NULL
nucleotide	NULL
76	NULL
to	NULL
nucleotide	NULL
329	NULL
of	NULL
the	NULL
published	NULL
cDNA	NULL
sequence	NULL
(	NULL
3	NULL
)	NULL
.	NULL

A	NULL
human	NULL
genomic	NULL
library	NULL
in	NULL
phage	NULL
lambda	NULL
FIX	NULL
(	NULL
Stratagene	NULL
)	NULL
was	NULL
screened	NULL
with	NULL
a	NULL
human	NULL
GATA-1	NULL
cDNA	NULL
.	NULL

Primer	NULL
extension	NULL
The	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
essentially	NULL
according	NULL
to	NULL
ref	NULL
.	NULL

13	NULL
.	NULL

Appropriate	NULL
primers	NULL
were	NULL
5'terminally	NULL
labelled	NULL
with	NULL
[	NULL
y°	NULL
>	NULL
-P	NULL
]	NULL
ATP	NULL
(	NULL
Amersham	NULL
,	NULL
3000	NULL
Ci/mmole	NULL
)	NULL
,	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

Primers	NULL
(	NULL
0.15-0.50	NULL
ngs	NULL
)	NULL
were	NULL
annealed	NULL
to	NULL
total	NULL
(	NULL
30	NULL
ugs	NULL
)	NULL
or	NULL
polyA*	NULL
RNA	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
from	NULL
mouse	NULL
erythroleukemic	NULL
cells	NULL
(	NULL
MEL	NULL
)	NULL
and	NULL
from	NULL
NIH3T3	NULL
fibroblasts	NULL
in	NULL
25	NULL
uls	NULL
of	NULL
80	NULL
%	NULL
formamide	NULL
,	NULL
containing	NULL
40	NULL
mM	NULL
PIPES	NULL
(	NULL
pH	NULL
6.4	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
at	NULL
30°C	NULL
for	NULL
15-18	NULL
hrs	NULL
.	NULL

Following	NULL
ethanol	NULL
precipitation	NULL
,	NULL
the	NULL
primer-RNA	NULL
hybrids	NULL
were	NULL
reverse	NULL
transcribed	NULL
and	NULL
the	NULL
reactions	NULL
processed	NULL
according	NULL
to	NULL
ref	NULL
.	NULL

13	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
analyzed	NULL
on	NULL
6	NULL
%	NULL
polyacrylamide-8M	NULL
urea	NULL
gels	NULL
.	NULL

RNAase	NULL
protection	NULL
analysis	NULL
(	NULL
7,13	NULL
)	NULL
A	NULL
405	NULL
nt	NULL
BamHI	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
GATA-1	NULL
gene	NULL
,	NULL
extending	NULL
(	NULL
Fig.4	NULL
)	NULL
from	NULL
the	NULL
most	NULL
5	NULL
``	NULL
part	NULL
of	NULL
the	NULL
first	NULL
intron	NULL
into	NULL
the	NULL
first	NULL
exon	NULL
and	NULL
the	NULL
5	NULL
'	NULL
-flanking	NULL
region	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
pGEM7	NULL
plasmid	NULL
.	NULL

A	NULL
*P-labelled	NULL
458	NULL
nt	NULL
.	NULL

long	NULL
antisense	NULL
RNA	NULL
probe	NULL
,	NULL
spanning	NULL
the	NULL
entire	NULL
fragment	NULL
and	NULL
extending	NULL
into	NULL
the	NULL
plasmid	NULL
,	NULL
was	NULL
obtained	NULL
by	NULL
transcribing	NULL
with	NULL
SP6	NULL
polymerase	NULL
the	NULL
plasmid	NULL
linearized	NULL
by	NULL
digestion	NULL
with	NULL
HindIII	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
(	NULL
20	NULL
ugs	NULL
)	NULL
was	NULL
hybridized	NULL
for	NULL
18	NULL
hrs	NULL
to	NULL
the	NULL
RNA	NULL
probe	NULL
(	NULL
~	NULL
0.5-2	NULL
x	NULL
106	NULL
cpm	NULL
)	NULL
at	NULL
39-45°C	NULL
in	NULL
30	NULL
uls	NULL
of	NULL
80	NULL
%	NULL
formamide	NULL
,	NULL
0.4M	NULL
NaCl	NULL
,	NULL
40	NULL
mM	NULL
PIPES	NULL
pH	NULL
6.4	NULL
,	NULL
1ImM	NULL
EDTA	NULL
,	NULL
and	NULL
then	NULL
digested	NULL
for	NULL
30	NULL
mins	NULL
at	NULL
30°C	NULL
in	NULL
300	NULL
uls	NULL
with	NULL
RNAase	NULL
A	NULL
and	NULL
Tl	NULL
(	NULL
40	NULL
pgs/ml	NULL
and	NULL
1	NULL
ug/ml	NULL
,	NULL
final	NULL
concentration	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
proteinase	NULL
K	NULL
digestion	NULL
and	NULL
phenol-chlorophorm	NULL
extraction	NULL
.	NULL

Gel	NULL
electrophoresis	NULL
was	NULL
in	NULL
standard	NULL
6	NULL
%	NULL
acrylamide	NULL
,	NULL
8M	NULL
urea	NULL
gels	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
Nuclear	NULL
extracts	NULL
from	NULL
exponentially	NULL
growing	NULL
cells	NULL
were	NULL
prepared	NULL
exactly	NULL
according	NULL
to	NULL
ref	NULL
.	NULL

14	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
leupeptin	NULL
,	NULL
aprotinin	NULL
and	NULL
pepstatin	NULL
.	NULL

5'-end	NULL
labelled	NULL
oligonucleotides	NULL
(	NULL
top	NULL
or	NULL
bottom	NULL
strand	NULL
)	NULL
were	NULL
annealed	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
complementary	NULL
oligonucleotide	NULL
[	NULL
15	NULL
]	NULL
and	NULL
repurified	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
to	NULL
DNA	NULL
and	NULL
electrophoretic	NULL
runs	NULL
were	NULL
according	NULL
to	NULL
refs	NULL
.	NULL

16,17	NULL
;	NULL
briefly	NULL
,	NULL
the	NULL
standard	NULL
assay	NULL
contained	NULL
(	NULL
in	NULL
a	NULL
20	NULL
pl	NULL
reaction	NULL
)	NULL
:	NULL
0.1-0.2	NULL
ngs	NULL
of	NULL
*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
5286	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

19	NULL
oligonucleotide	NULL
,	NULL
1-5	NULL
ugs	NULL
of	NULL
nuclear	NULL
protein	NULL
,	NULL
3	NULL
ugs	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
2	NULL
ugs	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
in	NULL
a	NULL
buffer	NULL
consisting	NULL
of	NULL
4	NULL
mM	NULL
spermidine	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
HCl	NULL
pH	NULL
7.9	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
.	NULL

When	NULL
purified	NULL
factors	NULL
were	NULL
used	NULL
instead	NULL
of	NULL
crude	NULL
extracts	NULL
,	NULL
100	NULL
ngs	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
/reaction	NULL
were	NULL
used	NULL
.	NULL

Unlabelled	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
as	NULL
specified	NULL
in	NULL
figure	NULL
legends	NULL
.	NULL

Incubation	NULL
was	NULL
at	NULL
20°C	NULL
for	NULL
30	NULL
'	NULL
.	NULL

Gel	NULL
electrophoresis	NULL
was	NULL
in	NULL
50	NULL
mM	NULL
Tris	NULL
borate	NULL
pH	NULL
8.2,1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
at	NULL
10	NULL
V	NULL
per	NULL
cm	NULL
for	NULL
2-3	NULL
hours	NULL
.	NULL

The	NULL
GATA	NULL
oligonucleotide	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
comprised	NULL
nucleotides	NULL
-718	NULL
to	NULL
-685	NULL
of	NULL
the	NULL
mouse	NULL
GATA-1	NULL
gene	NULL
.	NULL

Three	NULL
mutated	NULL
versions	NULL
of	NULL
this	NULL
oligonucleotide	NULL
were	NULL
also	NULL
used	NULL
:	NULL
5'-mutation	NULL
:	NULL
TGA	NULL
to	NULL
GTC	NULL
(	NULL
-708	NULL
to	NULL
-706	NULL
)	NULL
3'-mutation	NULL
:	NULL
TC	NULL
to	NULL
CA	NULL
(	NULL
-696	NULL
to	NULL
-695	NULL
)	NULL
5'+3	NULL
'	NULL
mutation	NULL
(	NULL
this	NULL
is	NULL
the	NULL
same	NULL
oligonucleotide	NULL
as	NULL
that	NULL
used	NULL
for	NULL
the	NULL
mutagenesis	NULL
of	NULL
the	NULL
GATA-1	NULL
enhancer	NULL
)	NULL
.	NULL

Bacterially	NULL
synthesized	NULL
GATA-1	NULL
A	NULL
Ncol-EcoRI	NULL
fragment	NULL
from	NULL
the	NULL
human	NULL
GATA-1	NULL
cDNA	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
E.coli	NULL
expression	NULL
vector	NULL
pAR	NULL
3040	NULL
NcoI	NULL
,	NULL
digested	NULL
with	NULL
NcoI	NULL
and	NULL
EcoRI	NULL
.	NULL

The	NULL
hybrid	NULL
protein	NULL
consists	NULL
of	NULL
11	NULL
N-ter	NULL
.	NULL

phage	NULL
residues	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
complete	NULL
GATA-1	NULL
coding	NULL
sequence	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
recombinant	NULL
protein	NULL
was	NULL
induced	NULL
in	NULL
transformed	NULL
E.coli	NULL
BL	NULL
21	NULL
cells	NULL
by	NULL
IPTG	NULL
.	NULL

GATA-1	NULL
was	NULL
extracted	NULL
by	NULL
the	NULL
method	NULL
of	NULL
inclusion	NULL
bodies	NULL
,	NULL
solubilized	NULL
by	NULL
6	NULL
M	NULL
Guanidinium	NULL
HCl	NULL
and	NULL
renaturated	NULL
by	NULL
dialysis	NULL
.	NULL

Plasmids	NULL
for	NULL
CAT	NULL
assay	NULL
A	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
GATA-1	NULL
promoter	NULL
,	NULL
comprising	NULL
nucleotides	NULL
-312	NULL
to	NULL
-31	NULL
,	NULL
was	NULL
obtained	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
using	NULL
oligonucleotides	NULL
(	NULL
1	NULL
and	NULL
2	NULL
,	NULL
see	NULL
below	NULL
)	NULL
ending	NULL
with	NULL
Hind	NULL
IH	NULL
linkers	NULL
and	NULL
was	NULL
ligated	NULL
into	NULL
the	NULL
Hind	NULL
III	NULL
site	NULL
of	NULL
the	NULL
pSVo	NULL
CAT	NULL
plasmid	NULL
(	NULL
18	NULL
)	NULL
to	NULL
generate	NULL
pSVo-GATA	NULL
.	NULL

A	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
upstream	NULL
conserved	NULL
region	NULL
(	NULL
from	NULL
nucleotide	NULL
-856	NULL
to	NULL
nucleotide	NULL
-655	NULL
)	NULL
,	NULL
ending	NULL
into	NULL
BamHI	NULL
linkers	NULL
,	NULL
was	NULL
also	NULL
obtained	NULL
by	NULL
PCR	NULL
,	NULL
using	NULL
oligonucleotides	NULL
3	NULL
and	NULL
4	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
and	NULL
ligated	NULL
either	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
3	NULL
'	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
of	NULL
the	NULL
pSVo-GATA	NULL
plasmid	NULL
,	NULL
or	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
located	NULL
exactly	NULL
at	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
GATA-1	NULL
promoter	NULL
fragment	NULL
of	NULL
the	NULL
same	NULL
plasmid	NULL
.	NULL

The	NULL
upstream	NULL
GATA-1	NULL
fragment	NULL
was	NULL
also	NULL
inserted	NULL
at	NULL
the	NULL
3	NULL
'	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
pSV	NULL
1	NULL
CAT	NULL
plasmid	NULL
(	NULL
18	NULL
)	NULL
or	NULL
upstream	NULL
to	NULL
the	NULL
SV40	NULL
promoter	NULL
in	NULL
a	NULL
modified	NULL
version	NULL
of	NULL
the	NULL
pSV1CAT	NULL
plasmid	NULL
generated	NULL
exactly	NULL
as	NULL
described	NULL
in	NULL
ref	NULL
.	NULL

18	NULL
,	NULL
with	NULL
the	NULL
further	NULL
addition	NULL
of	NULL
Bglll	NULL
linkers	NULL
(	NULL
into	NULL
which	NULL
the	NULL
fragment	NULL
was	NULL
inserted	NULL
)	NULL
.	NULL

A	NULL
mutated	NULL
version	NULL
of	NULL
the	NULL
upstream	NULL
GATA-1	NULL
fragment	NULL
was	NULL
obtained	NULL
by	NULL
PCR	NULL
(	NULL
19	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
mutated	NULL
sequence	NULL
(	NULL
in	NULL
the	NULL
sense	NULL
orientation	NULL
)	NULL
was	NULL
used	NULL
to	NULL
amplify	NULL
the	NULL
region	NULL
from	NULL
nucleotide	NULL
-718	NULL
to	NULL
nucleotide	NULL
-655	NULL
(	NULL
in	NULL
conjunction	NULL
with	NULL
oligonucleotide	NULL
4	NULL
)	NULL
.	NULL

The	NULL
complementary	NULL
version	NULL
of	NULL
the	NULL
same	NULL
mutated	NULL
oligonucleotide	NULL
was	NULL
used	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
oligonucleotide	NULL
3	NULL
,	NULL
to	NULL
amplify	NULL
the	NULL
region	NULL
from	NULL
position	NULL
-856	NULL
to	NULL
-685	NULL
.	NULL

The	NULL
amplified	NULL
fragments	NULL
were	NULL
purified	NULL
by	NULL
acrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
mixed	NULL
in	NULL
equimolar	NULL
amounts	NULL
,	NULL
denatured	NULL
and	NULL
further	NULL
amplified	NULL
using	NULL
only	NULL
oligonucleotides	NULL
3	NULL
and	NULL
4	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
desired	NULL
full	NULL
size	NULL
fragment	NULL
containing	NULL
the	NULL
expected	NULL
mutation	NULL
.	NULL

Oligonucleotides	NULL
1	NULL
and	NULL
2	NULL
encompass	NULL
nucleotides	NULL
-312	NULL
to	NULL
-291	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
-31	NULL
to	NULL
-52	NULL
(	NULL
antisense	NULL
)	NULL
;	NULL
oligonucleotides	NULL
3	NULL
and	NULL
4	NULL
nucleotides	NULL
-856	NULL
to	NULL
-837	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
-655	NULL
to	NULL
-674	NULL
(	NULL
antisense	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
mutated	NULL
oligonucleotide	NULL
(	NULL
-718	NULL
to	NULL
-685	NULL
)	NULL
is	NULL
shown	NULL
below	NULL
in	NULL
its	NULL
sense	NULL
version	NULL
(	NULL
mutated	NULL
nucleotide	NULL
in	NULL
bold	NULL
characters	NULL
)	NULL
.	NULL

5	NULL
CGA	NULL
GTC	NULL
CAT	NULL
CGT	NULL
CTA	NULL
AGA	NULL
CTT	NULL
ACA	NULL
TGC	NULL
TGC	NULL
CCC	NULL
A	NULL
Transfections	NULL
and	NULL
CAT	NULL
assay	NULL
2X10	NULL
'	NULL
K562	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
exactly	NULL
as	NULL
described	NULL
in	NULL
ref	NULL
.	NULL

7	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10-50	NULL
ugs	NULL
of	NULL
the	NULL
appropriate	NULL
plasmids	NULL
.	NULL

1x	NULL
10U937	NULL
cells	NULL
were	NULL
electroporated	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
0.4	NULL
ml	NULL
at	NULL
250	NULL
V	NULL
,	NULL
960	NULL
uF	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
ugs	NULL
of	NULL
plasmids	NULL
.	NULL

Hep3B	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
,	NULL
using	NULL
15	NULL
ugs	NULL
of	NULL
plasmids	NULL
.	NULL

At	NULL
least	NULL
two	NULL
independent	NULL
preparations	NULL
of	NULL
each	NULL
plasmid	NULL
were	NULL
tested	NULL
.	NULL

Two	NULL
days	NULL
after	NULL
transfection	NULL
(	NULL
one	NULL
day	NULL
in	NULL
the	NULL
case	NULL
of	NULL
U937	NULL
)	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
lysates	NULL
,	NULL
containing	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
,	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
by	NULL
measuring	NULL
conversion	NULL
of	NULL
'4C-chloramphenicol	NULL
to	NULL
acetylated	NULL
forms	NULL
(	NULL
by	NULL
thin	NULL
layer	NULL
chromatography	NULL
)	NULL
and	NULL
to	NULL
the	NULL
butyrylated	NULL
form	NULL
(	NULL
by	NULL
phase	NULL
extraction	NULL
)	NULL
[	NULL
20	NULL
]	NULL
,	NULL
as	NULL
described	NULL
in	NULL
ref	NULL
.	NULL

7	NULL
.	NULL

Some	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
-galactosidase	NULL
reporter	NULL
plasmid	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Results	NULL
obtained	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
this	NULL
plasmid	NULL
,	NULL
or	NULL
in	NULL
its	NULL
presence	NULL
and	NULL
normalized	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
its	NULL
activity	NULL
,	NULL
were	NULL
essentially	NULL
identical	NULL
.	NULL

RESULTS	NULL
Homology	NULL
between	NULL
the	NULL
5'-flanking	NULL
regions	NULL
of	NULL
mouse	NULL
and	NULL
human	NULL
GATA-1	NULL
genes	NULL
Sequencing	NULL
of	NULL
mouse	NULL
GATA-1	NULL
genomic	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
indicates	NULL
that	NULL
the	NULL
5'-untranslated	NULL
part	NULL
of	NULL
the	NULL
cDNA	NULL
sequence	NULL
is	NULL
split	NULL
by	NULL
an	NULL
intron	NULL
.	NULL

The	NULL
initiator	NULL
ATG	NULL
lies	NULL
in	NULL
the	NULL
second	NULL
exon	NULL
20	NULL
nucleotides	NULL
downstream	NULL
from	NULL
the	NULL
boundary	NULL
between	NULL
first	NULL
intron	NULL
and	NULL
exon	NULL
:	NULL
the	NULL
most	NULL
5'-nucleotide	NULL
of	NULL
the	NULL
previously	NULL
published	NULL
cDNA	NULL
sequence	NULL
lies	NULL
in	NULL
the	NULL
first	NULL
exon	NULL
at	NULL
position	NULL
-49	NULL
relative	NULL
to	NULL
the	NULL
first	NULL
exon-intron	NULL
boundary	NULL
.	NULL

~860	NULL
GGAGTCCACTCTGGGTGTCACCTCAGTTTCCCGCCTCTAACGTAGTATGGCGGGCAAGAAGTTGAGGCACTGTCCC	NULL
TGTG	NULL
~280	NULL
CATCCCCTACCCTGCCCCCCAGCCCCAAGACAGCCTGTTACTGCGGCACCAACAGCCACAGTCGAGTCCATC	NULL
TGATAAGA	NULL
-200	NULL
CTTATCTGCTGCCCCAGAGCAGGCCAGAGC	NULL
TGGCGTAAGCCCCAGGCACGAGCCGAAGCACTAAAGAAGTGTATGTACCC	NULL
~620	NULL
TTACCCACTAGTCC	NULL
TGGCC	NULL
TAGTACCCCAGACTGCT	NULL
TCATAGAGGTGGCCTGCAGCCTCTGCTTGAAATGCTCCCAAAAC	NULL
~540	NULL
TCTGAGCCTCATTCTTCTCACC	NULL
TGCAAAATGGGTACAGCTATATCCCCCTTTCTCCAGCATTCAGGAGGGGCTCACGCG	NULL
~460	NULL
CATACAGGTCCAACCCACACATACCC	NULL
TGGTACACAGTAGGGGCTTTCCTCACTGAAAGAAACTAGTAGTAAAACATGAAA	NULL
-380	NULL
CTTAGATCTTGACTAATTGCTCATATGACT	NULL
TGACTGGACAC	NULL
TGGACTCCACAGAAGCCAAGGCAAAGGGGATCCAACAAC	NULL
~300	NULL
Spi	NULL
Spi	NULL
cace	NULL
Sp1	NULL
crGcaca	NULL
TAGACAGGAAGGGCGGAGGGAC	NULL
TAGAGCCTAAAAGGTCC	NULL
TCCACAAGGAGGCGGCACACCCCETCCCCTcA	NULL
-220	NULL
_	NULL
cace	NULL
Spi	NULL
Spi	NULL
Spi	NULL
Spi	NULL
CTGCCCCACCCACTGGGGCACCAGCCACTCCCTGGGGAGGAM	NULL
(	NULL
lGQAGGGAGAAGGTGAGTGGGAGGGAGGGAG	NULL
‘	NULL
KSCGG	NULL
-140	NULL
Spi	NULL
Spi	NULL
vor	NULL
Spi	NULL
a	NULL
GEGGGC	NULL
TGGCAGGAGGGAGAGAAGGGAGACTCAGAGCCAAGGCCAGTGAGGACTECCTTGGGATCACCCTGAACTCGTCA	NULL
-60	NULL
-19	NULL
+1	NULL
TACCACTAAGGTGGCTGAATCCTCTGCATCAACAAGCCCAG/GT	NULL
.	NULL

.	NULL

int	NULL
ron	NULL
.	NULL

.	NULL

.	NULL

AG/GTTCAACCCCAGTGTTCCCATG	NULL
Figure	NULL
1	NULL
.	NULL

Sequence	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
mouse	NULL
GATA-1	NULL
gene	NULL
,	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
and	NULL
of	NULL
the	NULL
exon-intron	NULL
borders	NULL
.	NULL

Numbering	NULL
starts	NULL
from	NULL
A	NULL
(	NULL
position	NULL
+1	NULL
)	NULL
in	NULL
the	NULL
initiator	NULL
ATG	NULL
in	NULL
the	NULL
second	NULL
exon	NULL
.	NULL

The	NULL
two	NULL
major	NULL
transcription	NULL
start	NULL
sites	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

Recognition	NULL
sites	NULL
for	NULL
DNA	NULL
binding	NULL
proteins	NULL
are	NULL
indicated	NULL
by	NULL
underlining	NULL
;	NULL
a	NULL
GATA	NULL
motif	NULL
is	NULL
shown	NULL
in	NULL
bold	NULL
characters	NULL
.	NULL

The	NULL
asterisk	NULL
marks	NULL
the	NULL
end	NULL
of	NULL
the	NULL
previously	NULL
published	NULL
cDNA	NULL
sequence	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
initiator	NULL
ATG	NULL
lies	NULL
in	NULL
the	NULL
secon	NULL
exon	NULL
of	NULL
the	NULL
human	NULL
GATA-1	NULL
gene	NULL
,	NULL
19	NULL
nucleotides	NULL
downstream	NULL
from	NULL
the	NULL
intron-exon	NULL
boundary	NULL
.	NULL

The	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
GATA-1	NULL
gene	NULL
shows	NULL
a	NULL
high	NULL
level	NULL
of	NULL
homology	NULL
to	NULL
the	NULL
corresponding	NULL
region	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
up	NULL
to	NULL
mouse	NULL
position	NULL
-235	NULL
,	NULL
where	NULL
the	NULL
two	NULL
sequences	NULL
start	NULL
to	NULL
diverge	NULL
.	NULL

Homologous	NULL
fragments	NULL
,	NULL
interrupted	NULL
by	NULL
gaps	NULL
and	NULL
insertions	NULL
,	NULL
are	NULL
detected	NULL
up	NULL
to	NULL
position	NULL
-355	NULL
,	NULL
where	NULL
the	NULL
two	NULL
sequences	NULL
completely	NULL
diverge	NULL
.	NULL

However	NULL
,	NULL
a	NULL
highly	NULL
homologous	NULL
region	NULL
(	NULL
~	NULL
90	NULL
%	NULL
)	NULL
is	NULL
detected	NULL
further	NULL
upstream	NULL
(	NULL
between	NULL
mouse	NULL
nucleotides	NULL
-665	NULL
and	NULL
-760	NULL
;	NULL
the	NULL
corresponding	NULL
region	NULL
in	NULL
the	NULL
human	NULL
gene	NULL
is	NULL
underlined	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Multiple	NULL
transcription	NULL
initiation	NULL
sites	NULL
upstream	NULL
to	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
mouse	NULL
GATA-1	NULL
gene	NULL
To	NULL
identify	NULL
the	NULL
CAP	NULL
site	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
primer	NULL
extension	NULL
experiments	NULL
on	NULL
RNA	NULL
from	NULL
mouse	NULL
erythroleukemic	NULL
cells	NULL
(	NULL
MEL	NULL
)	NULL
using	NULL
primers	NULL
corresponding	NULL
to	NULL
either	NULL
the	NULL
second	NULL
exon	NULL
or	NULL
the	NULL
first	NULL
exon	NULL
and	NULL
putative	NULL
flanking	NULL
sequences	NULL
(	NULL
Figs	NULL
.	NULL

3A	NULL
and	NULL
4A	NULL
)	NULL
.	NULL

Two	NULL
major	NULL
CAP	NULL
sites	NULL
and	NULL
several	NULL
clustered	NULL
minor	NULL
sites	NULL
are	NULL
detected	NULL
.	NULL

Identical	NULL
CAP	NULL
sites	NULL
are	NULL
identified	NULL
with	NULL
three	NULL
different	NULL
primers	NULL
mapping	NULL
on	NULL
the	NULL
first	NULL
exon	NULL
,	NULL
indicating	NULL
that	NULL
in	NULL
this	NULL
region	NULL
the	NULL
mRNA	NULL
is	NULL
colinear	NULL
with	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
.	NULL

The	NULL
same	NULL
CAP	NULL
sites	NULL
are	NULL
also	NULL
identified	NULL
with	NULL
a	NULL
primer	NULL
mapping	NULL
on	NULL
the	NULL
second	NULL
exon	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
large	NULL
majority	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
of	NULL
the	NULL
transcripts	NULL
originate	NULL
5	NULL
'	NULL
to	NULL
the	NULL
first	NULL
exon	NULL
;	NULL
the	NULL
only	NULL
possible	NULL
exception	NULL
is	NULL
a	NULL
site	NULL
defined	NULL
by	NULL
a	NULL
~	NULL
320	NULL
nt	NULL
band	NULL
,	NULL
representing	NULL
<	NULL
5	NULL
%	NULL
of	NULL
all	NULL
start	NULL
sites	NULL
,	NULL
that	NULL
is	NULL
visible	NULL
only	NULL
with	NULL
a	NULL
primer	NULL
mapping	NULL
on	NULL
the	NULL
second	NULL
exon	NULL
,	NULL
and	NULL
only	NULL
using	NULL
polyA*	NULL
RNA	NULL
.	NULL

The	NULL
location	NULL
in	NULL
the	NULL
first	NULL
intron	NULL
,	NULL
or	NULL
elsewhere	NULL
,	NULL
of	NULL
this	NULL
minor	NULL
start	NULL
site	NULL
has	NULL
not	NULL
been	NULL
investigated	NULL
.	NULL

No	NULL
visible	NULL
extension	NULL
was	NULL
obtained	NULL
using	NULL
fibroblast	NULL
(	NULL
NIH3T3	NULL
)	NULL
RNA	NULL
with	NULL
primers	NULL
1-4	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
erythroid	NULL
specificity	NULL
of	NULL
the	NULL
GATA-1	NULL
RNA	NULL
.	NULL

To	NULL
independently	NULL
verify	NULL
the	NULL
primer	NULL
extension	NULL
results	NULL
.	NULL

RNAase	NULL
mapping	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
using	NULL
an	NULL
RNA	NULL
probe	NULL
starting	NULL
in	NULL
the	NULL
first	NULL
intron	NULL
,	NULL
and	NULL
extending	NULL
into	NULL
the	NULL
first	NULL
exon	NULL
and	NULL
5'-flanking	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Using	NULL
MEL	NULL
RNA	NULL
,	NULL
multiple	NULL
protected	NULL
bands	NULL
are	NULL
observed	NULL
;	NULL
qualitatively	NULL
identical	NULL
results	NULL
are	NULL
obtained	NULL
by	NULL
hybridizing	NULL
at	NULL
a	NULL
range	NULL
of	NULL
temperatures	NULL
between	NULL
39°	NULL
and	NULL
45°	NULL
,	NULL
and	NULL
by	NULL
digestion	NULL
of	NULL
the	NULL
hybrids	NULL
at	NULL
various	NULL
RNAase	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

NIH	NULL
3T3	NULL
fibroblasts	NULL
do	NULL
not	NULL
show	NULL
any	NULL
band	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
primer	NULL
extension	NULL
experiments	NULL
.	NULL

Overall	NULL
,	NULL
there	NULL
is	NULL
a	NULL
very	NULL
precise	NULL
concordance	NULL
between	NULL
CAP	NULL
sites	NULL
detected	NULL
by	NULL
primer	NULL
extension	NULL
experiments	NULL
and	NULL
those	NULL
indicated	NULL
by	NULL
RNAase	NULL
-820	NULL
Tce	NULL
trrrorr	NULL
recorererer	NULL
ormeommec	NULL
Tatcocact	NULL
~740	NULL
corcaageaatcarcooreecrorcacercaermreooscorecansccaccareeceecacaagaasrreaceccacte	NULL
~660	NULL
Tcooresqrertooracceccacaceoercacccommeacaccerermactocescoccaacasccaceerceccracarc	NULL
~580	NULL
~500	NULL
xc	NULL
aat	NULL
aaccatatc	NULL
~420	NULL
TAMGGGCTTTACTC	NULL
TTTCATTTATCTTIGGTTICAGCCTAT	NULL
~340	NULL
TrrGcr	NULL
A	NULL
cc	NULL
~260	NULL
-180	NULL
caccase	NULL
Arceceras	NULL
~100	NULL
crececal	NULL
+1	NULL
+20	NULL
G/GT	NULL
...	NULL
intron	NULL
.	NULL

.	NULL

.	NULL

AG/GTTAATCCCCAGAGGCTCcATG	NULL
Figure	NULL
2	NULL
.	NULL

Sequence	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
human	NULL
GATA-1	NULL
gene	NULL
,	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
and	NULL
of	NULL
the	NULL
exon-intron	NULL
borders	NULL
.	NULL

Position	NULL
+1	NULL
corresponds	NULL
to	NULL
A	NULL
in	NULL
the	NULL
initiator	NULL
ATG	NULL
in	NULL
the	NULL
second	NULL
exon	NULL
.	NULL

The	NULL
upstream	NULL
regions	NULL
of	NULL
homology	NULL
with	NULL
the	NULL
mouse	NULL
GATA-1	NULL
gene	NULL
are	NULL
underlined	NULL
.	NULL

A	NULL
GATA	NULL
motif	NULL
is	NULL
shown	NULL
in	NULL
bold	NULL
characters	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

19	NULL
5287	NULL
396	NULL
aso	NULL
-	NULL
®	NULL
1797	NULL
“	NULL
65	NULL
Q	NULL
104	NULL
98	NULL
-	NULL
«	NULL
a	NULL
94	NULL
s	NULL
:	NULL
-	NULL
L	NULL
M	NULL
1	NULL
2	NULL
3	NULL
430	NULL
12343	NULL
ACcGT	NULL
MEL	NULL
_	NULL
NIH	NULL
__	NULL
MEL	NULL
NIH	NULL
3T3	NULL
,	NULL
|	NULL
3T3	NULL
A	NULL
POLY	NULL
A+	NULL
TOTAL	NULL
RNA	NULL
RNA	NULL
«	NULL
WD	NULL
-517	NULL
-	NULL
>	NULL
.	NULL

w	NULL
we	NULL
«	NULL
p	NULL
-	NULL
396	NULL
&	NULL
#	NULL
-350	NULL
ﬂ	NULL
[	NULL
-I	NULL
«	NULL
»	NULL
-179	NULL
ie	NULL
172	NULL
)	NULL
-	NULL
‘	NULL
66L	NULL
163	NULL
160	NULL
155	NULL
152	NULL
147	NULL
7	NULL
143	NULL
7	NULL
134	NULL
~	NULL
130	NULL
127	NULL
1234	NULL
120	NULL
~	NULL
116	NULL
111	NULL
~	NULL
109	NULL
``	NULL
104	NULL
go	NULL
94/5	NULL
-	NULL
W	NULL
8	NULL
-~	NULL
#	NULL
-55	NULL
#	NULL
-5	NULL
123456	NULL
7	NULL
M	NULL
A	NULL
C	NULL
G	NULL
T	NULL
MEL	NULL
NIH	NULL
3T3	NULL
Figure	NULL
3	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
5'-end	NULL
of	NULL
murine	NULL
GATA-1	NULL
mRNA	NULL
.	NULL

A	NULL
:	NULL
Primer	NULL
extension	NULL
.	NULL

The	NULL
primers	NULL
used	NULL
for	NULL
these	NULL
experiments	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
numbers	NULL
(	NULL
see	NULL
Figure	NULL
3	NULL
)	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

MEL	NULL
or	NULL
NIH	NULL
3T3	NULL
total	NULL
or	NULL
poly	NULL
A*	NULL
RNA	NULL
was	NULL
used	NULL
.	NULL

Sequencing	NULL
reactions	NULL
on	NULL
cloned	NULL
DNA	NULL
using	NULL
primer	NULL
2	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
;	NULL
labelled	NULL
size	NULL
markers	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
CAP	NULL
sites	NULL
identified	NULL
with	NULL
primer	NULL
1	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
of	NULL
the	NULL
corresponding	NULL
lane	NULL
.	NULL

Note	NULL
that	NULL
identical	NULL
patterns	NULL
of	NULL
extension	NULL
are	NULL
obtained	NULL
with	NULL
primers	NULL
mapping	NULL
downstream	NULL
from	NULL
primer	NULL
1	NULL
;	NULL
the	NULL
resulting	NULL
bands	NULL
are	NULL
increased	NULL
in	NULL
size	NULL
in	NULL
proportion	NULL
to	NULL
the	NULL
distance	NULL
of	NULL
primers	NULL
2-4	NULL
from	NULL
primer	NULL
1	NULL
.	NULL

B	NULL
:	NULL
RNAase	NULL
protection	NULL
.	NULL

Total	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
poly	NULL
A*	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
MEL	NULL
and	NULL
total	NULL
NIH	NULL
3T3	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
RNA	NULL
was	NULL
analyzed	NULL
.	NULL

The	NULL
hybridization	NULL
temperature	NULL
was	NULL
45°	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
43°	NULL
%	NULL
(	NULL
lanes	NULL
2,4-6,7	NULL
)	NULL
and	NULL
39°	NULL
(	NULL
Cane	NULL
3	NULL
)	NULL
.	NULL

RNAase	NULL
concentrations	NULL
were	NULL
halved	NULL
for	NULL
samples	NULL
run	NULL
in	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
.	NULL

Arrow	NULL
:	NULL
residual	NULL
undigested	NULL
probe	NULL
;	NULL
M	NULL
:	NULL
labelled	NULL
size	NULL
markers	NULL
.	NULL

Sequencing	NULL
reactions	NULL
of	NULL
the	NULL
cloned	NULL
first	NULL
exon	NULL
were	NULL
obtained	NULL
using	NULL
primer	NULL
2	NULL
,	NULL
and	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

5288	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

19	NULL
A	NULL
TRANSCRIPTION	NULL
START	NULL
STES	NULL
INTRON	NULL
20	NULL
19	NULL
0	NULL
44	NULL
«	NULL
200	NULL
+172	NULL
111_	NULL
04	NULL
T	NULL
ATG	NULL
PRIMER	NULL
_	NULL
``	NULL
i	NULL
i	NULL
EXTENSION	NULL
«	NULL
_	NULL
__	NULL
@	NULL
_	NULL
»	NULL
«	NULL
51	NULL
g	NULL
!	NULL

-22	NULL
28	NULL
+2	NULL
16	NULL
,	NULL
+15	NULL
TRANSCRIPTION	NULL
START	NULL
SITES	NULL
INTRON	NULL
+312	NULL
RNAase	NULL
HB	NULL
1720	NULL
0000	NULL
.	NULL

#	NULL
2	NULL
+20	NULL
f	NULL
SP6	NULL
PROTECTION	NULL
Jk___-_L_J_—+	NULL
...	NULL
...	NULL
...	NULL
Nak	NULL
``	NULL
45m	NULL
;	NULL
3	NULL
w	NULL
C	NULL
-	NULL
on	NULL
l	NULL
:	NULL
PfPfff	NULL
S	NULL
Gg	NULL
&	NULL
T	NULL
--	NULL
J	NULL
v	NULL
v	NULL
v_	NULL
_v	NULL
v	NULL
_v	NULL
v	NULL
v	NULL
_v	NULL
v_	NULL
_v	NULL
_	NULL
v_v	NULL
esup	NULL
o	NULL
o	NULL
0	NULL
0	NULL
0	NULL
0	NULL
e	NULL
e	NULL
e	NULL
e	NULL
0	NULL
o	NULL
oe	NULL
e	NULL
o	NULL
e0	NULL
Figure	NULL
4	NULL
.	NULL

Comparison	NULL
of	NULL
results	NULL
obtained	NULL
by	NULL
primer	NULL
extension	NULL
and	NULL
RNAase	NULL
protection	NULL
experiments	NULL
.	NULL

A	NULL
:	NULL
Primer	NULL
extension	NULL
.	NULL

The	NULL
location	NULL
of	NULL
primers	NULL
on	NULL
the	NULL
cDNA	NULL
sequence	NULL
and	NULL
the	NULL
region	NULL
where	NULL
transcription	NULL
start	NULL
sites	NULL
are	NULL
located	NULL
,	NULL
are	NULL
indicated	NULL
.	NULL

Position	NULL
-111	NULL
marks	NULL
the	NULL
nucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
end	NULL
of	NULL
the	NULL
published	NULL
human	NULL
GATA-1	NULL
cDNA	NULL
.	NULL

The	NULL
data	NULL
are	NULL
based	NULL
on	NULL
5	NULL
experiments	NULL
with	NULL
primers	NULL
1	NULL
and	NULL
3	NULL
,	NULL
and	NULL
3	NULL
experiments	NULL
with	NULL
primers	NULL
2	NULL
and	NULL
4	NULL
.	NULL

B	NULL
:	NULL
RNAase	NULL
protection	NULL
.	NULL

The	NULL
SP6	NULL
transcribed	NULL
probe	NULL
is	NULL
shown	NULL
;	NULL
sequences	NULL
belonging	NULL
to	NULL
the	NULL
intron	NULL
are	NULL
dotted	NULL
.	NULL

Protected	NULL
sequences	NULL
are	NULL
indicated	NULL
by	NULL
a	NULL
solid	NULL
line	NULL
,	NULL
unprotected	NULL
sequences	NULL
by	NULL
a	NULL
broken	NULL
line	NULL
.	NULL

H	NULL
:	NULL
Hind	NULL
II	NULL
;	NULL
B	NULL
:	NULL
BamHI	NULL
.	NULL

C	NULL
:	NULL
Interpretation	NULL
of	NULL
primer	NULL
extension	NULL
(	NULL
top	NULL
)	NULL
and	NULL
RNAase	NULL
protection	NULL
experiments	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

Triangles	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
CAP	NULL
sites	NULL
mapped	NULL
by	NULL
primer	NULL
extension	NULL
,	NULL
circles	NULL
the	NULL
positions	NULL
of	NULL
sites	NULL
mapped	NULL
by	NULL
RNAase	NULL
protection	NULL
.	NULL

Solid	NULL
symbols	NULL
:	NULL
strong	NULL
sites	NULL
;	NULL
open	NULL
symbols	NULL
:	NULL
weak	NULL
sites	NULL
.	NULL

Note	NULL
that	NULL
from	NULL
the	NULL
primer	NULL
extension	NULL
data	NULL
colinearity	NULL
between	NULL
mRNA	NULL
and	NULL
genomic	NULL
sequence	NULL
must	NULL
extend	NULL
at	NULL
least	NULL
up	NULL
to	NULL
the	NULL
5'end	NULL
of	NULL
primer	NULL
1	NULL
.	NULL

If	NULL
colinearity	NULL
were	NULL
interrupted	NULL
upstream	NULL
to	NULL
this	NULL
position	NULL
,	NULL
all	NULL
the	NULL
resulting	NULL
RNAase	NULL
protected	NULL
bands	NULL
should	NULL
be	NULL
shorter	NULL
than	NULL
expected	NULL
(	NULL
contrary	NULL
to	NULL
the	NULL
observed	NULL
results	NULL
)	NULL
.	NULL

protection	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
;	NULL
some	NULL
additional	NULL
fainter	NULL
bands	NULL
might	NULL
either	NULL
represent	NULL
minor	NULL
start	NULL
sites	NULL
undetected	NULL
by	NULL
primer	NULL
extension	NULL
or	NULL
degradation	NULL
fragments	NULL
.	NULL

Ubiquitous	NULL
nuclear	NULL
proteins	NULL
bind	NULL
in	NULL
vitro	NULL
to	NULL
the	NULL
proximal	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
GATA-1	NULL
gene	NULL
As	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
5'-flanking	NULL
region	NULL
contains	NULL
multiple	NULL
canonical	NULL
(	NULL
GGGCG	NULL
)	NULL
(	NULL
22	NULL
)	NULL
and	NULL
variant	NULL
(	NULL
GGGAG	NULL
)	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
ubiquitous	NULL
factor	NULL
Sp1	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
two	NULL
well	NULL
conserved	NULL
CACCC	NULL
boxes	NULL
,	NULL
which	NULL
are	NULL
also	NULL
known	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
to	NULL
bind	NULL
ubiquitous	NULL
factors	NULL
,	NULL
including	NULL
Sp1	NULL
,	NULL
are	NULL
present	NULL
just	NULL
upstream	NULL
to	NULL
the	NULL
CAP	NULL
sites	NULL
region	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
shows	NULL
a	NULL
representative	NULL
nuclear	NULL
protein	NULL
binding	NULL
experiment	NULL
using	NULL
a	NULL
labelled	NULL
fragment	NULL
from	NULL
the	NULL
CACCC	NULL
box	NULL
region	NULL
from	NULL
nucleotide	NULL
-312	NULL
to	NULL
nucleotide	NULL
-	NULL
191	NULL
,	NULL
in	NULL
a	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
fragment	NULL
generates	NULL
several	NULL
retarded	NULL
bands	NULL
,	NULL
one	NULL
of	NULL
which	NULL
(	NULL
indicated	NULL
by	NULL
a	NULL
closed	NULL
square	NULL
)	NULL
comigrates	NULL
with	NULL
the	NULL
major	NULL
band	NULL
obtained	NULL
using	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
the	NULL
SV40	NULL
promoter	NULL
and	NULL
from	NULL
a	NULL
mutant	NULL
(	NULL
~198	NULL
T-C	NULL
)	NULL
y-globin	NULL
promoter	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
bind	NULL
efficiently	NULL
to	NULL
purified	NULL
Sp1	NULL
(	NULL
and	NULL
to	NULL
other	NULL
ubiquitous	NULL
proteins	NULL
)	NULL
(	NULL
24-26	NULL
)	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Excess	NULL
unlabelled	NULL
y-globin	NULL
fragment	NULL
or	NULL
Sp1	NULL
oligonucleotide	NULL
efficiently	NULL
compete	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
all	NULL
the	NULL
major	NULL
bands	NULL
,	NULL
including	NULL
the	NULL
slower	NULL
ones	NULL
,	NULL
generated	NULL
by	NULL
the	NULL
GATA-1	NULL
promoter	NULL
fragment	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
the	NULL
~y-globin	NULL
promoter	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

An	NULL
asterisk	NULL
denotes	NULL
a	NULL
band	NULL
generated	NULL
by	NULL
the	NULL
-198	NULL
oligonucleotide	NULL
that	NULL
is	NULL
not	NULL
due	NULL
to	NULL
Sp1	NULL
(	NULL
24	NULL
)	NULL
and	NULL
is	NULL
not	NULL
generated	NULL
by	NULL
the	NULL
GATA-1	NULL
fragment	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
an	NULL
unrelated	NULL
oligonucleotide	NULL
from	NULL
the	NULL
y-globin	NULL
CCAAT	NULL
box	NULL
region	NULL
(	NULL
24	NULL
)	NULL
does	NULL
not	NULL
complete	NULL
the	NULL
GATA-1	NULL
bands	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
band	NULL
comigrating	NULL
with	NULL
that	NULL
generated	NULL
by	NULL
the	NULL
y-globin	NULL
and	NULL
the	NULL
SV40	NULL
oligonucleotides	NULL
represents	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
single	NULL
Sp1	NULL
molecule	NULL
,	NULL
while	NULL
the	NULL
slower	NULL
bands	NULL
are	NULL
due	NULL
to	NULL
the	NULL
additional	NULL
binding	NULL
of	NULL
other	NULL
Sp1	NULL
molecules	NULL
and/or	NULL
of	NULL
different	NULL
proteins	NULL
.	NULL

To	NULL
test	NULL
these	NULL
possibilities	NULL
,	NULL
highly	NULL
purified	NULL
Sp1	NULL
,	NULL
obtained	NULL
by	NULL
affinity	NULL
chromatography	NULL
(	NULL
22	NULL
,	NULL
24	NULL
)	NULL
,	NULL
was	NULL
used	NULL
,	NULL
originating	NULL
bands	NULL
comigrating	NULL
with	NULL
the	NULL
major	NULL
bands	NULL
obtained	NULL
with	NULL
the	NULL
crude	NULL
extract	NULL
Figure	NULL
5	NULL
.	NULL

Binding	NULL
of	NULL
a	NULL
GATA-1	NULL
promoter	NULL
fragment	NULL
including	NULL
the	NULL
CACC	NULL
box	NULL
to	NULL
nuclear	NULL
proteins	NULL
.	NULL

Labelled	NULL
fragments	NULL
used	NULL
for	NULL
gel	NULL
shift	NULL
assays	NULL
are	NULL
indicated	NULL
below	NULL
the	NULL
figure	NULL
and	NULL
unlabelled	NULL
competitor	NULL
DNAs	NULL
,	NULL
if	NULL
present	NULL
,	NULL
above	NULL
the	NULL
figure	NULL
.	NULL

A	NULL
:	NULL
Binding	NULL
of	NULL
oligonucleotides	NULL
containing	NULL
Spl	NULL
recognition	NULL
motifs	NULL
from	NULL
the	NULL
SV40	NULL
promoter	NULL
(	NULL
SV40	NULL
,	NULL
see	NULL
refs	NULL
.	NULL

24-26	NULL
)	NULL
,	NULL
a	NULL
mutant	NULL
y-globin	NULL
promoter	NULL
(	NULL
-198	NULL
T-C	NULL
,	NULL
see	NULL
ref	NULL
.	NULL

23	NULL
)	NULL
and	NULL
the	NULL
GATA-1	NULL
promoter	NULL
fragment	NULL
(	NULL
GATA	NULL
pr	NULL
.	NULL
)	NULL

.	NULL

In	NULL
lanes	NULL
1-3	NULL
purified	NULL
Spl	NULL
was	NULL
used	NULL
;	NULL
3	NULL
pgrs	NULL
.	NULL

of	NULL
nuclear	NULL
extract	NULL
were	NULL
used	NULL
in	NULL
lanes	NULL
4-10	NULL
.	NULL

Unlabelled	NULL
competitors	NULL
were	NULL
added	NULL
in	NULL
a	NULL
200-fold	NULL
molar	NULL
excess	NULL
.	NULL

X	NULL
is	NULL
an	NULL
unrelated	NULL
oligonucleotide	NULL
from	NULL
the	NULL
y-globin	NULL
CCAAT	NULL
box	NULL
region	NULL
(	NULL
24	NULL
)	NULL
.	NULL

B	NULL
:	NULL
Binding	NULL
to	NULL
the	NULL
GATA-1	NULL
promoter	NULL
fragment	NULL
of	NULL
proteins	NULL
from	NULL
erythroid	NULL
K562	NULL
,	NULL
Colon	NULL
Carcinoma	NULL
(	NULL
CaCo	NULL
)	NULL
and	NULL
B-lymphoid	NULL
(	NULL
Raji	NULL
)	NULL
cells	NULL
.	NULL

GATA-1	NULL
A	NULL
mutated	NULL
0	NULL
GATA-1	NULL
GATA-1	NULL
Competitor	NULL
=	NULL
=	NULL
Competitor	NULL
=-	NULL
a	NULL
<	NULL
u	NULL
«	NULL
aum	NULL
with	NULL
CH	NULL
mee	NULL
sous	NULL
«	NULL
mee	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

19	NULL
5289	NULL
mutated	NULL
GATA-1	NULL
cee	NULL
-	NULL
5	NULL
T	NULL
J	NULL
5	NULL
«	NULL
«	NULL
inne	NULL
5G	NULL
ff	NULL
SHe	NULL
.	NULL

E	NULL
3	NULL
GATA-1	NULL
y-globin	NULL
GATA1	NULL
§	NULL
g	NULL
5	NULL
E-	NULL
Tm	NULL
fe	NULL
g	NULL
2	NULL
m	NULL
in	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
GL—~—'ATA1	NULL
sty	NULL
*	NULL
GATA-1	NULL
Figure	NULL
6	NULL
.	NULL

Binding	NULL
of	NULL
an	NULL
oligonucleotide	NULL
from	NULL
the	NULL
upstream	NULL
conserved	NULL
region	NULL
of	NULL
the	NULL
murine	NULL
GATA-1	NULL
gene	NULL
to	NULL
nuclear	NULL
proteins	NULL
from	NULL
K562	NULL
cells	NULL
and	NULL
to	NULL
GATA-1	NULL
.	NULL

Labelled	NULL
oligonucleotides	NULL
used	NULL
for	NULL
gel	NULL
shift	NULL
assays	NULL
are	NULL
indicated	NULL
below	NULL
the	NULL
figure	NULL
and	NULL
unlabelled	NULL
competitor	NULL
oligonucleotides	NULL
,	NULL
if	NULL
present	NULL
,	NULL
above	NULL
the	NULL
figure	NULL
.	NULL

A	NULL
:	NULL
binding	NULL
of	NULL
the	NULL
oligonucleotide	NULL
from	NULL
the	NULL
upstream	NULL
GATA-1	NULL
gene	NULL
conserved	NULL
region	NULL
(	NULL
GATA	NULL
)	NULL
(	NULL
nucleotides	NULL
-718	NULL
to	NULL
-685	NULL
)	NULL
.	NULL

Competitors	NULL
are	NULL
:	NULL
&	NULL
,	NULL
a	NULL
GATA-1	NULL
binding	NULL
oligonucleotide	NULL
from	NULL
the	NULL
mouse	NULL
-globin	NULL
promoter	NULL
(	NULL
27	NULL
)	NULL
;	NULL
GATA	NULL
,	NULL
and	NULL
its	NULL
mutated	NULL
version	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
added	NULL
at	NULL
50	NULL
,	NULL
120	NULL
and	NULL
300-fold	NULL
molar	NULL
excess	NULL
.	NULL

B	NULL
:	NULL
Binding	NULL
of	NULL
the	NULL
GATA	NULL
oligonucleotide	NULL
and	NULL
of	NULL
an	NULL
oligonucleotide	NULL
from	NULL
the	NULL
y-globin	NULL
promoter	NULL
.	NULL

This	NULL
oligonucleotide	NULL
binds	NULL
either	NULL
GATA-1	NULL
or	NULL
OTF-1	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Lanes	NULL
1-6	NULL
:	NULL
3	NULL
ugs	NULL
of	NULL
nuclear	NULL
proteins	NULL
;	NULL
lanes	NULL
7-9	NULL
:	NULL
7	NULL
pgs	NULL
.	NULL

Unlabelled	NULL
a-competitor	NULL
was	NULL
at	NULL
a	NULL
50	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
150-	NULL
and	NULL
300-fold	NULL
(	NULL
lanes	NULL
8	NULL
,	NULL
9	NULL
)	NULL
molar	NULL
excess	NULL
;	NULL
GATA-1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
at	NULL
50-fold	NULL
excess	NULL
,	NULL
and	NULL
mutated	NULL
GATA-1	NULL
at	NULL
50-200-fold	NULL
excess	NULL
.	NULL

C	NULL
:	NULL
Bacterially	NULL
synthesized	NULL
GATA-1	NULL
was	NULL
added	NULL
to	NULL
oligonucleotides	NULL
GATA	NULL
,	NULL
mutated	NULL
GATA	NULL
and	NULL
y-globin	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
y-globin	NULL
oligonucleotide	NULL
;	NULL
lane	NULL
2	NULL
GATA	NULL
with	NULL
2	NULL
ugs	NULL
of	NULL
K562	NULL
nuclear	NULL
proteins	NULL
.	NULL

D	NULL
:	NULL
bacterially	NULL
synthesized	NULL
GATA-1	NULL
was	NULL
added	NULL
to	NULL
the	NULL
normal	NULL
GATA	NULL
oligonucleotide	NULL
,	NULL
to	NULL
a	NULL
3'-mutated	NULL
and	NULL
to	NULL
a	NULL
5'-mutated	NULL
GATA-1	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

The	NULL
band	NULL
running	NULL
ahead	NULL
of	NULL
the	NULL
major	NULL
GATA-1	NULL
band	NULL
is	NULL
a	NULL
known	NULL
degradation	NULL
product	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
8	NULL
)	NULL
.	NULL

(	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
GATA-1	NULL
promoter	NULL
fragment	NULL
binds	NULL
Spl	NULL
(	NULL
and	NULL
possibly	NULL
other	NULL
ubiquitous	NULL
proteins	NULL
)	NULL
,	NULL
generating	NULL
multiple	NULL
retarded	NULL
bands	NULL
,	NULL
which	NULL
correspond	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
one	NULL
or	NULL
more	NULL
Spl	NULL
molecules	NULL
.	NULL

We	NULL
have	NULL
further	NULL
confirmed	NULL
these	NULL
conclusions	NULL
using	NULL
overlapping	NULL
sets	NULL
of	NULL
oligonucleotides	NULL
individually	NULL
encompassing	NULL
the	NULL
CACCC	NULL
boxes	NULL
and	NULL
the	NULL
major	NULL
clusters	NULL
of	NULL
Spl	NULL
motifs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
identical	NULL
results	NULL
are	NULL
obtained	NULL
either	NULL
using	NULL
erythroid	NULL
or	NULL
non	NULL
erythroid	NULL
nuclear	NULL
extracts	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

A	NULL
strong	NULL
conserved	NULL
GATA-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
upstream	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
GATA-1	NULL
gene	NULL
The	NULL
high	NULL
degree	NULL
of	NULL
conservation	NULL
between	NULL
mouse	NULL
and	NULL
man	NULL
of	NULL
the	NULL
-665	NULL
to	NULL
-760	NULL
region	NULL
prompted	NULL
an	NULL
investigation	NULL
of	NULL
its	NULL
DNA	NULL
binding	NULL
properties	NULL
.	NULL

These	NULL
experiments	NULL
identify	NULL
a	NULL
region	NULL
showing	NULL
erythroid	NULL
-specific	NULL
binding	NULL
.	NULL

A	NULL
duplicated	NULL
,	NULL
inverted	NULL
GATA	NULL
motif	NULL
,	NULL
perfectly	NULL
conserved	NULL
between	NULL
mouse	NULL
and	NULL
man	NULL
(	NULL
Figures	NULL
1	NULL
and	NULL
2	NULL
)	NULL
is	NULL
present	NULL
in	NULL
this	NULL
region	NULL
.	NULL

An	NULL
oligonucleotide	NULL
including	NULL
this	NULL
motif	NULL
yields	NULL
a	NULL
band	NULL
comigrating	NULL
with	NULL
the	NULL
GATA-1	NULL
band	NULL
generated	NULL
by	NULL
a	NULL
previously	NULL
well	NULL
characterized	NULL
(	NULL
27	NULL
)	NULL
y-globin	NULL
oligonucleotide	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

The	NULL
band	NULL
generated	NULL
with	NULL
the	NULL
labelled	NULL
oligonucleotide	NULL
from	NULL
the	NULL
GATA-1	NULL
gene	NULL
can	NULL
be	NULL
competed	NULL
either	NULL
by	NULL
a	NULL
strong	NULL
GATA-1	NULL
binding	NULL
oligonucleotide	NULL
(	NULL
mouse	NULL
-globin	NULL
promoter	NULL
,	NULL
see	NULL
ref	NULL
.	NULL

27	NULL
)	NULL
or	NULL
by	NULL
the	NULL
GATA-1	NULL
gene	NULL
oligonucleotide	NULL
itself	NULL
,	NULL
at	NULL
ratios	NULL
indicating	NULL
that	NULL
the	NULL
site	NULL
in	NULL
the	NULL
GATA-1	NULL
gene	NULL
is	NULL
stronger	NULL
than	NULL
that	NULL
in	NULL
the	NULL
-globin	NULL
promoter	NULL
(	NULL
compare	NULL
lanes	NULL
2-6	NULL
in	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
GATA-1	NULL
band	NULL
generated	NULL
with	NULL
the	NULL
labelled	NULL
y-globin	NULL
oligonucleotide	NULL
is	NULL
more	NULL
efficiently	NULL
competed	NULL
by	NULL
unlabelled	NULL
GATA-1	NULL
gene	NULL
oligonucleotide	NULL
than	NULL
by	NULL
«	NULL
-globin	NULL
oligonucleotide	NULL
(	NULL
Figure	NULL
6B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
a	NULL
mutant	NULL
GATA-1	NULL
gene	NULL
oligonucleotide	NULL
failed	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
,	NULL
indicating	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
interaction	NULL
(	NULL
Figure	NULL
6B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

When	NULL
the	NULL
binding	NULL
reaction	NULL
with	NULL
the	NULL
GATA-1	NULL
gene	NULL
oligonucleotide	NULL
is	NULL
carried	NULL
out	NULL
at	NULL
low	NULL
concentrations	NULL
of	NULL
nuclear	NULL
extract	NULL
(	NULL
1	NULL
to	NULL
3	NULL
ugs	NULL
of	NULL
protein	NULL
)	NULL
,	NULL
a	NULL
single	NULL
retarded	NULL
band	NULL
is	NULL
observed	NULL
;	NULL
however	NULL
,	NULL
already	NULL
at	NULL
7	NULL
ugs	NULL
a	NULL
strong	NULL
,	NULL
slower	NULL
band	NULL
is	NULL
additionally	NULL
detected	NULL
,	NULL
that	NULL
is	NULL
also	NULL
competed	NULL
efficiently	NULL
by	NULL
unlabelled	NULL
GATA-1	NULL
binding	NULL
oligonucleotides	NULL
(	NULL
Figure	NULL
6B	NULL
,	NULL
lanes	NULL
6-9	NULL
)	NULL
.	NULL

This	NULL
band	NULL
might	NULL
be	NULL
due	NULL
either	NULL
to	NULL
a	NULL
complex	NULL
between	NULL
GATA-1	NULL
and	NULL
a	NULL
different	NULL
protein	NULL
,	NULL
or	NULL
represent	NULL
the	NULL
binding	NULL
of	NULL
two	NULL
GATA-1	NULL
proteins	NULL
to	NULL
the	NULL
same	NULL
molecule	NULL
.	NULL

To	NULL
address	NULL
this	NULL
point	NULL
,	NULL
we	NULL
used	NULL
bacterially	NULL
synthesized	NULL
human	NULL
GATA-1	NULL
protein	NULL
;	NULL
this	NULL
protein	NULL
generates	NULL
a	NULL
single	NULL
band	NULL
of	NULL
the	NULL
expected	NULL
mobility	NULL
when	NULL
using	NULL
the	NULL
y-globin	NULL
GATA-1	NULL
binding	NULL
oligonucleotide	NULL
,	NULL
that	NULL
is	NULL
known	NULL
to	NULL
bind	NULL
a	NULL
single	NULL
GATA-1	NULL
molecule	NULL
(	NULL
8	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
GATA-1	NULL
gene	NULL
oligonucleotide	NULL
,	NULL
'bacterial	NULL
'	NULL
GATA-1	NULL
generates	NULL
both	NULL
the	NULL
expected	NULL
and	NULL
the	NULL
slower	NULL
bands	NULL
;	NULL
no	NULL
binding	NULL
is	NULL
observed	NULL
with	NULL
the	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
.	NULL

If	NULL
the	NULL
3'-GATA-1	NULL
motif	NULL
only	NULL
is	NULL
destroyed	NULL
,	NULL
the	NULL
fragment	NULL
generates	NULL
only	NULL
the	NULL
fast	NULL
,	NULL
but	NULL
not	NULL
the	NULL
slow	NULL
,	NULL
band	NULL
(	NULL
Figure	NULL
6D	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
5	NULL
motif	NULL
is	NULL
still	NULL
able	NULL
to	NULL
bind	NULL
GATA-1	NULL
;	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
mutation	NULL
of	NULL
the	NULL
5'-motif	NULL
is	NULL
sufficient	NULL
to	NULL
abolish	NULL
or	NULL
greatly	NULL
reduce	NULL
the	NULL
binding	NULL
(	NULL
Figure	NULL
6D	NULL
,	NULL
5290	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

19	NULL
pSVO-GATA	NULL
[	NULL
~~~	NULL
~BAT	NULL
--	NULL
-	NULL
1	NULL
+	NULL
0.2	NULL
AZ	NULL
g	NULL
;	NULL
E	NULL
E	NULL
Y-	NULL
226+	NULL
71	NULL
E	NULL
E.	NULL
C	NULL
--	NULL
ans	NULL
+15.9	NULL
E	NULL
E	NULL
0	NULL
rar	NULL
so	NULL
E	NULL
E	NULL
_	NULL
s17	NULL
s108	NULL
pSV1	NULL
-C-	NULL
1+	NULL
0.2	NULL
E	NULL
E	NULL
--	NULL
r	NULL
-	NULL
sree	NULL
mos	NULL
E	NULL
E	NULL
q	NULL
~	NULL
Car-	NULL
--	NULL
-	NULL
128+	NULL
24	NULL
E	NULL
E.	NULL
2	NULL
&	NULL
35—4	NULL
175+	NULL
53	NULL
GATAAGACTTATCT	NULL
~	NULL
E	NULL
``	NULL
3.3+	NULL
0.8	NULL
GTCTAAGACTTACAT	NULL
Figure	NULL
7	NULL
.	NULL

Relative	NULL
CAT	NULL
activities	NULL
in	NULL
erythroid	NULL
K562	NULL
cells	NULL
of	NULL
reporter	NULL
plasmids	NULL
containing	NULL
or	NULL
not	NULL
the	NULL
conserved	NULL
upstream	NULL
GATA-1	NULL
gene	NULL
region	NULL
.	NULL

The	NULL
fragment	NULL
(	NULL
E	NULL
)	NULL
was	NULL
linked	NULL
in	NULL
the	NULL
orientation	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
to	NULL
either	NULL
the	NULL
pSV	NULL
1	NULL
plasmid	NULL
or	NULL
to	NULL
the	NULL
pSVo	NULL
plasmid	NULL
driven	NULL
by	NULL
a	NULL
GATA-1	NULL
gene	NULL
promoter	NULL
fragment	NULL
.	NULL

The	NULL
mutations	NULL
introduced	NULL
into	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
results	NULL
are	NULL
averages	NULL
+	NULL
standard	NULL
deviations	NULL
,	NULL
from	NULL
4-12	NULL
experiments	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
pSV	NULL
1	NULL
or	NULL
of	NULL
pSVo-GATA	NULL
plasmids	NULL
,	NULL
transfected	NULL
in	NULL
parallel	NULL
experiments	NULL
to	NULL
the	NULL
other	NULL
tested	NULL
constructs	NULL
,	NULL
were	NULL
taken	NULL
to	NULL
represent	NULL
activity	NULL
=	NULL
1	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
pSVo-GATA	NULL
is	NULL
2.5	NULL
fold	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
pSVo	NULL
without	NULL
any	NULL
added	NULL
promoter	NULL
and	NULL
that	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
enhancer-containing	NULL
constructs	NULL
(	NULL
pSV	NULL
1	NULL
+	NULL
E	NULL
and	NULL
pSVo-GATA	NULL
+	NULL
E	NULL
)	NULL
are	NULL
2-5	NULL
fold	NULL
higher	NULL
than	NULL
those	NULL
of	NULL
constructs	NULL
containing	NULL
an	NULL
overactive	NULL
y-globin	NULL
promoter	NULL
(	NULL
-175	NULL
T-C	NULL
HPFH	NULL
,	NULL
see	NULL
ref	NULL
.	NULL

7	NULL
)	NULL
.	NULL

lane	NULL
3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
che	NULL
3'-motif	NULL
may	NULL
be	NULL
weak	NULL
,	NULL
and	NULL
that	NULL
GATA-1	NULL
may	NULL
cooperatively	NULL
bind	NULL
to	NULL
it	NULL
only	NULL
after	NULL
one	NULL
molecule	NULL
of	NULL
GATA-1	NULL
has	NULL
bound	NULL
to	NULL
the	NULL
5'-motif	NULL
.	NULL

This	NULL
interpretation	NULL
is	NULL
supported	NULL
by	NULL
DMS	NULL
interference	NULL
experiments	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
when	NULL
the	NULL
binding	NULL
experiment	NULL
is	NULL
carried	NULL
out	NULL
at	NULL
low	NULL
protein	NULL
concentration	NULL
,	NULL
to	NULL
generate	NULL
a	NULL
single	NULL
band	NULL
,	NULL
methylation	NULL
of	NULL
the	NULL
G	NULL
at	NULL
positions	NULL
-707	NULL
(	NULL
top	NULL
strand	NULL
)	NULL
and	NULL
-709	NULL
(	NULL
bottom	NULL
strand	NULL
)	NULL
strongly	NULL
interferes	NULL
with	NULL
binding	NULL
,	NULL
while	NULL
methylation	NULL
at	NULL
positions	NULL
-700	NULL
and	NULL
-695	NULL
(	NULL
bottom	NULL
strand	NULL
)	NULL
has	NULL
a	NULL
smaller	NULL
effect	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
dimeric	NULL
GATA-1	NULL
site	NULL
is	NULL
the	NULL
only	NULL
one	NULL
we	NULL
have	NULL
detected	NULL
in	NULL
~	NULL
900	NULL
nucleotides	NULL
of	NULL
upstream	NULL
sequence	NULL
.	NULL

A	NULL
GATAGACAG	NULL
sequence	NULL
exists	NULL
immediately	NULL
upstream	NULL
to	NULL
the	NULL
CACCC	NULL
boxes	NULL
of	NULL
the	NULL
mouse	NULL
,	NULL
but	NULL
not	NULL
the	NULL
human	NULL
,	NULL
gene	NULL
;	NULL
this	NULL
sequence	NULL
,	NULL
binds	NULL
a	NULL
different	NULL
,	NULL
ubiquitous	NULL
protein	NULL
,	NULL
but	NULL
not	NULL
the	NULL
erythroid	NULL
GATA-1	NULL
protein	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
distal	NULL
conserved	NULL
region	NULL
has	NULL
erythroid	NULL
specific	NULL
enhancer	NULL
activity	NULL
Transfection	NULL
experiments	NULL
in	NULL
which	NULL
fragments	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
,	NULL
extending	NULL
up	NULL
to	NULL
position	NULL
-600	NULL
,	NULL
linked	NULL
to	NULL
the	NULL
CAT-reporter	NULL
gene	NULL
,	NULL
were	NULL
introduced	NULL
into	NULL
erythroid	NULL
or	NULL
non	NULL
erythroid	NULL
cells	NULL
,	NULL
consistently	NULL
failed	NULL
to	NULL
demonstrate	NULL
any	NULL
activity	NULL
of	NULL
the	NULL
GATA-1	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
when	NULL
a	NULL
fragment	NULL
including	NULL
the	NULL
upstream	NULL
conserved	NULL
region	NULL
is	NULL
linked	NULL
to	NULL
a	NULL
~	NULL
300	NULL
nucleotide	NULL
promoter	NULL
fragment	NULL
of	NULL
the	NULL
GATA-1	NULL
gene	NULL
,	NULL
it	NULL
greatly	NULL
stimulates	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
erythroid	NULL
KS562	NULL
cells	NULL
.	NULL

The	NULL
effect	NULL
is	NULL
similar	NULL
,	NULL
whether	NULL
the	NULL
distal	NULL
region	NULL
is	NULL
placed	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
to	NULL
the	NULL
promoter	NULL
,	NULL
and	NULL
independent	NULL
of	NULL
the	NULL
orientation	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

U937	NULL
Hep3B	NULL
Hela	NULL
pSV1	NULL
--	NULL
-	NULL
TXT	NULL
Ff	NULL
;	NULL
1	NULL
£0.1	NULL
1	NULL
10.4	NULL
1	NULL
+0.5	NULL
E	NULL
LED—f	NULL
;	NULL
4	NULL
+0.6	NULL
-	NULL
3.9	NULL
+15	NULL
E-	NULL
&	NULL
.	NULL

YC	NULL
_c	NULL
___	NULL
--	NULL
--	NULL
47:03	NULL
-	NULL
a	NULL
+09	NULL
E	NULL
--	NULL
-	NULL
CX	NULL
}	NULL
———J	NULL
2	NULL
+0.2	NULL
1.5	NULL
+0.2	NULL
=	NULL
&	NULL
-	NULL
|	NULL
0.8	NULL
£04	NULL
pSvo	NULL
C-BRTJ	NULL
--	NULL
--	NULL
-	NULL
-	NULL
1	NULL
+0.6	NULL
1	NULL
+03	NULL
pSV0-GATA	NULL
b-	NULL
-	NULL
1	NULL
+:0o4a	NULL
-	NULL
07	NULL
+04	NULL
4120.	NULL
,	NULL
E	NULL
Y	NULL
--	NULL
r-p___-_-_	NULL
--	NULL
-	NULL
-	NULL
o.7	NULL
+os	NULL
E	NULL
-	NULL
hi	NULL
=	NULL
1.2	NULL
+0.5	NULL
Figure	NULL
8	NULL
.	NULL

Relative	NULL
CAT	NULL
activities	NULL
in	NULL
non	NULL
erythroid	NULL
cells	NULL
of	NULL
CAT	NULL
plasmids	NULL
.	NULL

The	NULL
results	NULL
are	NULL
averages	NULL
+	NULL
standard	NULL
deviations	NULL
,	NULL
from	NULL
4	NULL
experiments	NULL
.	NULL

To	NULL
evaluate	NULL
whether	NULL
the	NULL
enhancing	NULL
effect	NULL
requires	NULL
the	NULL
cooperation	NULL
with	NULL
a	NULL
specific	NULL
sequence	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
the	NULL
distal	NULL
region	NULL
was	NULL
also	NULL
linked	NULL
to	NULL
the	NULL
SV40	NULL
promoter	NULL
(	NULL
minus	NULL
enhancer	NULL
)	NULL
region	NULL
of	NULL
the	NULL
pSV	NULL
1	NULL
plasmid	NULL
;	NULL
the	NULL
stimulation	NULL
is	NULL
the	NULL
same	NULL
as	NULL
obtained	NULL
when	NULL
the	NULL
distal	NULL
region	NULL
is	NULL
linked	NULL
to	NULL
the	NULL
GATA-1	NULL
promoter	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
is	NULL
almost	NULL
completely	NULL
dependent	NULL
on	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
;	NULL
a	NULL
mutation	NULL
of	NULL
this	NULL
site	NULL
,	NULL
preventing	NULL
the	NULL
binding	NULL
of	NULL
GATA-1	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
,	NULL
abolishes	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
is	NULL
restricted	NULL
to	NULL
erythroid	NULL
cells	NULL
(	NULL
Figure	NULL
8	NULL
)	NULL
.	NULL

In	NULL
transfection	NULL
experiments	NULL
using	NULL
epithelial	NULL
carcinoma	NULL
HeLa	NULL
,	NULL
hepatoma	NULL
Hep3B	NULL
and	NULL
monocytic	NULL
U937	NULL
cells	NULL
,	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
pSV	NULL
1	NULL
constructs	NULL
containing	NULL
the	NULL
enhancer	NULL
were	NULL
very	NULL
low	NULL
and	NULL
similar	NULL
,	NULL
or	NULL
only	NULL
slightly	NULL
higher	NULL
(	NULL
2-4	NULL
fold	NULL
)	NULL
,	NULL
than	NULL
those	NULL
of	NULL
the	NULL
control	NULL
constructs	NULL
without	NULL
the	NULL
upstream	NULL
region	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
low	NULL
level	NULL
of	NULL
stimulation	NULL
obtained	NULL
with	NULL
some	NULL
constructs	NULL
was	NULL
not	NULL
dependent	NULL
on	NULL
the	NULL
GATA	NULL
motifs	NULL
,	NULL
as	NULL
it	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
the	NULL
construct	NULL
containing	NULL
the	NULL
mutant	NULL
GATA-1	NULL
motif	NULL
.	NULL

The	NULL
pSVo-GATA	NULL
constructs	NULL
were	NULL
completely	NULL
inactive	NULL
.	NULL

DISCUSSION	NULL
In	NULL
mammals	NULL
,	NULL
GATA-1	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
normal	NULL
erythroblasts	NULL
(	NULL
1	NULL
,	NULL
9	NULL
)	NULL
,	NULL
megakaryocytes	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
,	NULL
mastcells	NULL
(	NULL
9	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
several	NULL
cell	NULL
lines	NULL
belonging	NULL
to	NULL
these	NULL
lineages	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
certain	NULL
non-transformed	NULL
early	NULL
myeloid	NULL
cell	NULL
lines	NULL
also	NULL
express	NULL
GATA-1	NULL
,	NULL
at	NULL
levels	NULL
that	NULL
are	NULL
inversely	NULL
proportional	NULL
to	NULL
the	NULL
degree	NULL
of	NULL
maturation	NULL
of	NULL
these	NULL
cells	NULL
;	NULL
treatment	NULL
with	NULL
myeloid	NULL
growth	NULL
factors	NULL
of	NULL
some	NULL
of	NULL
these	NULL
cells	NULL
leads	NULL
to	NULL
decreased	NULL
GATA-1	NULL
expression	NULL
(	NULL
21	NULL
)	NULL
.	NULL

These	NULL
data	NULL
have	NULL
led	NULL
to	NULL
the	NULL
suggestion	NULL
that	NULL
the	NULL
GATA-1	NULL
gene	NULL
may	NULL
be	NULL
first	NULL
activated	NULL
in	NULL
a	NULL
common	NULL
progenitor	NULL
to	NULL
some	NULL
or	NULL
all	NULL
of	NULL
these	NULL
lineages	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
21	NULL
)	NULL
,	NULL
and	NULL
then	NULL
differentially	NULL
regulated	NULL
(	NULL
maintained	NULL
or	NULL
extinguished	NULL
)	NULL
in	NULL
the	NULL
differentiated	NULL
progeny	NULL
(	NULL
21	NULL
)	NULL
.	NULL

To	NULL
elucidate	NULL
this	NULL
complex	NULL
regulation	NULL
,	NULL
we	NULL
have	NULL
cloned	NULL
the	NULL
mouse	NULL
(	NULL
and	NULL
human	NULL
)	NULL
GATA-1	NULL
genes	NULL
,	NULL
and	NULL
started	NULL
a	NULL
search	NULL
for	NULL
regulatory	NULL
elements	NULL
by	NULL
dissecting	NULL
the	NULL
5'-flanking	NULL
region	NULL
.	NULL

The	NULL
proximal	NULL
5	NULL
'	NULL
-flanking	NULL
region	NULL
is	NULL
structurally	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
a	NULL
typical	NULL
'ubiquitous	NULL
'	NULL
promoter	NULL
,	NULL
lacking	NULL
TATA	NULL
and	NULL
CCAAT	NULL
boxes	NULL
,	NULL
and	NULL
containing	NULL
several	NULL
binding	NULL
elements	NULL
for	NULL
Sp1	NULL
and	NULL
other	NULL
ubiquitous	NULL
factors	NULL
(	NULL
Figures	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
)	NULL
,	NULL
immediately	NULL
upstream	NULL
or	NULL
interspersed	NULL
with	NULL
multiple	NULL
transcription	NULL
initiation	NULL
sites	NULL
(	NULL
Figures	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Not	NULL
surprisingly	NULL
,	NULL
it	NULL
has	NULL
little	NULL
or	NULL
no	NULL
activity	NULL
,	NULL
per	NULL
se	NULL
,	NULL
in	NULL
transfection	NULL
experiments	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
upstream	NULL
region	NULL
has	NULL
a	NULL
strong	NULL
enhancer	NULL
activity	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

Its	NULL
conservation	NULL
between	NULL
mouse	NULL
and	NULL
man	NULL
argues	NULL
in	NULL
favour	NULL
of	NULL
an	NULL
'in	NULL
vivo	NULL
'	NULL
role	NULL
for	NULL
this	NULL
enhancer	NULL
.	NULL

The	NULL
enhancer	NULL
has	NULL
a	NULL
strong	NULL
GATA-1	NULL
binding	NULL
motif	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
and	NULL
its	NULL
activity	NULL
in	NULL
erythroid	NULL
cells	NULL
is	NULL
almost	NULL
completely	NULL
dependent	NULL
on	NULL
the	NULL
integrity	NULL
of	NULL
this	NULL
motif	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

In	NULL
non-erythroid	NULL
cells	NULL
,	NULL
the	NULL
enhancer	NULL
,	NULL
whether	NULL
normal	NULL
or	NULL
mutated	NULL
,	NULL
is	NULL
substantially	NULL
inactive	NULL
(	NULL
Figure	NULL
8	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
erythroid	NULL
GATA-1	NULL
protein	NULL
,	NULL
other	NULL
partially	NULL
tissue	NULL
restricted	NULL
or	NULL
ubiquitous	NULL
GATA	NULL
binding	NULL
proteins	NULL
have	NULL
been	NULL
recently	NULL
discovered	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
these	NULL
new	NULL
proteins	NULL
bind	NULL
to	NULL
the	NULL
enhancer	NULL
sequence	NULL
,	NULL
and	NULL
we	NULL
can	NULL
not	NULL
presently	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
proteins	NULL
participate	NULL
in	NULL
the	NULL
erythroid	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

However	NULL
,	NULL
the	NULL
very	NULL
low	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
in	NULL
several	NULL
types	NULL
of	NULL
non	NULL
erythroid	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
its	NULL
lack	NULL
of	NULL
dependence	NULL
on	NULL
the	NULL
GATA	NULL
motif	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
strongly	NULL
argue	NULL
that	NULL
non	NULL
erythroid	NULL
GATA-binding	NULL
proteins	NULL
do	NULL
not	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
,	NULL
per	NULL
se	NULL
,	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

Rather	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
GATA-1	NULL
,	NULL
by	NULL
binding	NULL
to	NULL
one	NULL
or	NULL
both	NULL
sites	NULL
in	NULL
the	NULL
enhancer	NULL
,	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
maintenance	NULL
or	NULL
stimulation	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
GATA-1	NULL
gene	NULL
,	NULL
following	NULL
its	NULL
initial	NULL
activation	NULL
in	NULL
the	NULL
unknown	NULL
progenitor	NULL
.	NULL

Other	NULL
GATA-1	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
first	NULL
intron	NULL
(	NULL
unpublished	NULL
)	NULL
might	NULL
also	NULL
cooperate	NULL
in	NULL
this	NULL
modulation	NULL
.	NULL

These	NULL
data	NULL
do	NULL
not	NULL
address	NULL
the	NULL
problem	NULL
of	NULL
the	NULL
initial	NULL
,	NULL
and	NULL
perhaps	NULL
transient	NULL
,	NULL
events	NULL
that	NULL
activate	NULL
,	NULL
or	NULL
derepress	NULL
,	NULL
the	NULL
GATA-1	NULL
gene	NULL
.	NULL

Understanding	NULL
whether	NULL
the	NULL
distal	NULL
enhancer	NULL
,	NULL
or	NULL
other	NULL
as	NULL
yet	NULL
unidentified	NULL
regions	NULL
,	NULL
are	NULL
involved	NULL
in	NULL
this	NULL
event	NULL
requires	NULL
further	NULL
investigations	NULL
and	NULL
the	NULL
utilization	NULL
of	NULL
hematopoietic	NULL
progenitor	NULL
cell	NULL
lines	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
study	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
chicken	NULL
GATA-1	NULL
gene	NULL
has	NULL
appeared	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
chicken	NULL
promoter	NULL
resembles	NULL
the	NULL
mouse	NULL
promoter	NULL
in	NULL
lacking	NULL
a	NULL
TATA	NULL
box	NULL
and	NULL
showing	NULL
multiple	NULL
transcription	NULL
start	NULL
sites	NULL
.	NULL

Cotransfection	NULL
experiments	NULL
indicate	NULL
that	NULL
GATA-1	NULL
may	NULL
regulate	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
other	NULL
unidentified	NULL
factors	NULL
,	NULL
this	NULL
promoter	NULL
.	NULL

Interestingly	NULL
,	NULL
however	NULL
,	NULL
the	NULL
major	NULL
GATA-1	NULL
binding	NULL
sites	NULL
are	NULL
in	NULL
close	NULL
proximity	NULL
to	NULL
the	NULL
CAP	NULL
sites	NULL
(	NULL
both	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
in	NULL
the	NULL
first	NULL
intron	NULL
)	NULL
,	NULL
in	NULL
contrast	NULL
with	NULL
the	NULL
distant	NULL
upstream	NULL
location	NULL
of	NULL
the	NULL
enhancer	NULL
in	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
genes	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
DNA	NULL
region	NULL
interposed	NULL
between	NULL
the	NULL
minimal	NULL
promoter	NULL
and	NULL
the	NULL
enhancer	NULL
in	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
genes	NULL
may	NULL
have	NULL
evolved	NULL
new	NULL
regulatory	NULL
functions	NULL
.	NULL

After	NULL
we	NULL
submitted	NULL
this	NULL
paper	NULL
,	NULL
an	NULL
other	NULL
study	NULL
of	NULL
the	NULL
mouse	NULL
GATA-1	NULL
promoter	NULL
has	NULL
been	NULL
reported	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
promoter	NULL
assay	NULL
,	NULL
a	NULL
moderate	NULL
(	NULL
~	NULL
4-fold	NULL
)	NULL
effect	NULL
of	NULL
the	NULL
distal	NULL
GATA-1	NULL
binding	NULL
motif	NULL
on	NULL
erythroid	NULL
expression	NULL
was	NULL
demonstrated	NULL
.	NULL

ACKNOWLEDGEMENTS	NULL
We	NULL
thank	NULL
Dr.	NULL
P.Ricciardi	NULL
for	NULL
providing	NULL
the	NULL
genomic	NULL
DNA	NULL
library	NULL
,	NULL
and	NULL
Dr.	NULL
C.	NULL
Santoro	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
purified	NULL
Sp1	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
research	NULL
grants	NULL
from	NULL
Progetti	NULL
Finalizzati	NULL
'Biotecnologie	NULL
e	NULL
Biostrumentazione	NULL
'	NULL
and	NULL
'Ingegneria	NULL
Genetica	NULL
'	NULL
,	NULL
CNR	NULL
.	NULL

A.R	NULL
.	NULL

,	NULL
S.C.	NULL
and	NULL
C.B	NULL
.	NULL

are	NULL
recipients	NULL
of	NULL
fellowships	NULL
from	NULL
IML	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

19	NULL
5291	NULL
REFERENCES	NULL
1	NULL
.	NULL

Mantovani	NULL
R.	NULL
,	NULL
Malgaretti	NULL
N.	NULL
,	NULL
Giglioni	NULL
B.	NULL
,	NULL
Comi	NULL
P.	NULL
,	NULL
Cappellini	NULL
N.	NULL
,	NULL
Nicolis	NULL
S	NULL
$	NULL
.	NULL

and	NULL
Ottolenghi	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
9349-9364	NULL
.	NULL

2	NULL
.	NULL

Wall	NULL
L.	NULL
,	NULL
deBoer	NULL
E.	NULL
and	NULL
Grosveld	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1089-1100	NULL
.	NULL

3	NULL
.	NULL

Tsai	NULL
$	NULL
.-F.	NULL
,	NULL
Martin	NULL
D.LK	NULL
.	NULL

,	NULL
Zon	NULL
LL	NULL
.	NULL

,	NULL
D'Andrea	NULL
A.D.	NULL
,	NULL
Wong	NULL
G.G	NULL
.	NULL

and	NULL
Orkin	NULL
S.H	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
339	NULL
,	NULL
446-451	NULL
.	NULL

4	NULL
.	NULL

Trainor	NULL
C.D	NULL
.	NULL

,	NULL
Evans	NULL
T.	NULL
,	NULL
Fensenfeld	NULL
G.	NULL
and	NULL
Boguski	NULL
M.B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
343	NULL
,	NULL
92-96	NULL
.	NULL

5	NULL
.	NULL

Mignotte	NULL
V.	NULL
,	NULL
Wall	NULL
L.	NULL
,	NULL
deBoer	NULL
E.	NULL
,	NULL
Grosveld	NULL
F.	NULL
and	NULL
Romeo	NULL
P.H	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
37-54	NULL
6.	NULL
deBoer	NULL
E.	NULL
,	NULL
Antoniou	NULL
M.	NULL
,	NULL
Mignotte	NULL
V.	NULL
,	NULL
Wall	NULL
L.	NULL
and	NULL
Grosveld	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
4203-4214	NULL
.	NULL

7	NULL
.	NULL

Nicolis	NULL
S.	NULL
,	NULL
Ronchi	NULL
A.	NULL
,	NULL
Malgaretti	NULL
N.	NULL
,	NULL
Mantovani	NULL
R.	NULL
,	NULL
Giglioni	NULL
B.	NULL
and	NULL
Ottolenghi	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
5509-5516	NULL
.	NULL

8	NULL
.	NULL

Martin	NULL
D.LK	NULL
.	NULL

,	NULL
Tsai	NULL
S.F	NULL
.	NULL

and	NULL
Orkin	NULL
S.H	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
338	NULL
,	NULL
435-438	NULL
.	NULL

9	NULL
.	NULL

Martin	NULL
D.LK	NULL
.	NULL

,	NULL
Zon	NULL
LL	NULL
.	NULL

,	NULL
Mutter	NULL
G.	NULL
and	NULL
Orkin	NULL
S.H	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
444-447	NULL
,	NULL
10	NULL
.	NULL

Romeo	NULL
,	NULL
P.H	NULL
.	NULL

,	NULL
Prandini	NULL
MH	NULL
.	NULL

,	NULL
Joulin	NULL
V.	NULL
,	NULL
Mignotte	NULL
V.	NULL
,	NULL
Prenant	NULL
M.	NULL
,	NULL
Vainchenker	NULL
W.	NULL
,	NULL
Marguerie	NULL
G.	NULL
and	NULL
Uzan	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
447-449	NULL
.	NULL

11	NULL
.	NULL

Pevny	NULL
L.	NULL
,	NULL
Simon	NULL
M.C	NULL
.	NULL

,	NULL
Robertson	NULL
E.	NULL
,	NULL
Klein	NULL
V.H	NULL
.	NULL

,	NULL
Tsai	NULL
S.	NULL
-F.	NULL
,	NULL
D'Agati	NULL
V.	NULL
,	NULL
Orkin	NULL
S.H	NULL
.	NULL

and	NULL
Costantini	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
349	NULL
,	NULL
257-260	NULL
.	NULL

12	NULL
.	NULL

Mori	NULL
L.	NULL
,	NULL
Ricciardi-Castagnoli	NULL
P.	NULL
and	NULL
Steinmetz	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Immunogenetics	NULL
28	NULL
,	NULL
136-138	NULL
.	NULL

13	NULL
.	NULL

Maniatis	NULL
R.	NULL
,	NULL
Fritsch	NULL
E.F.	NULL
and	NULL
Sambrook	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
University	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
.	NULL

14	NULL
.	NULL

Dignam	NULL
J.B.	NULL
,	NULL
Lebowitz	NULL
R.M	NULL
.	NULL

and	NULL
Roeder	NULL
R.G	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

15	NULL
.	NULL

Superti-Furga	NULL
G.	NULL
,	NULL
Barberis	NULL
A.	NULL
,	NULL
Schaffner	NULL
G.	NULL
and	NULL
Busslinger	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
3099-3117	NULL
.	NULL

16	NULL
.	NULL

Singh	NULL
H.	NULL
,	NULL
Sen	NULL
R.	NULL
,	NULL
Baltimore	NULL
D.	NULL
and	NULL
Sharp	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
319	NULL
,	NULL
151-158	NULL
.	NULL

17	NULL
.	NULL

Mantovani	NULL
R.	NULL
,	NULL
Superti-Furga	NULL
G.	NULL
,	NULL
Gilman	NULL
J.	NULL
and	NULL
Ottolenghi	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6681-6691	NULL
.	NULL

18	NULL
.	NULL

Gorman	NULL
C.M	NULL
.	NULL

,	NULL
Moffat	NULL
L.F.	NULL
and	NULL
Howard	NULL
B.H	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
.	NULL

19	NULL
.	NULL

Becker-André	NULL
M.	NULL
and	NULL
Halbrock	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
9437-9446	NULL
.	NULL

20	NULL
.	NULL

Seed	NULL
B.	NULL
and	NULL
Sheen	NULL
J.Y	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Gene	NULL
67	NULL
,	NULL
271-277	NULL
.	NULL

21	NULL
.	NULL

Crotta	NULL
S.	NULL
,	NULL
Nicolis	NULL
S.	NULL
,	NULL
Ronchi	NULL
A.	NULL
,	NULL
Ottolenghi	NULL
S.	NULL
,	NULL
Ruzzi	NULL
L.	NULL
,	NULL
Shimada	NULL
Y.	NULL
,	NULL
Migliaccio	NULL
A.R	NULL
.	NULL

and	NULL
Migliaccio	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
6863-6869	NULL
.	NULL

22	NULL
.	NULL

Briggs	NULL
MR.	NULL
,	NULL
Kadonaga	NULL
J.T	NULL
.	NULL

,	NULL
Bell	NULL
S.P	NULL
.	NULL

and	NULL
Tjian	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
234	NULL
,	NULL
47-52	NULL
.	NULL

23	NULL
.	NULL

Jones	NULL
K.A	NULL
.	NULL

,	NULL
Kadonaga	NULL
J.T	NULL
.	NULL

,	NULL
Luciw	NULL
P.A	NULL
.	NULL

and	NULL
Tjian	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
232	NULL
,	NULL
755-758	NULL
.	NULL

24	NULL
.	NULL

Ronchi	NULL
A.	NULL
,	NULL
Nicolis	NULL
S.	NULL
,	NULL
Santoro	NULL
C.	NULL
and	NULL
Ottolenghi	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
17	NULL
,	NULL
10231-10241	NULL
.	NULL

25	NULL
.	NULL

Xiao	NULL
J.-H.	NULL
,	NULL
Davidson	NULL
I.	NULL
,	NULL
Macchi	NULL
M.	NULL
,	NULL
Rosales	NULL
R.	NULL
,	NULL
Vigneron	NULL
M.	NULL
,	NULL
Staub	NULL
A.	NULL
and	NULL
Chambon	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

1	NULL
,	NULL
794-807	NULL
.	NULL

26	NULL
.	NULL

Davidson	NULL
L.	NULL
,	NULL
Xiao	NULL
J.H	NULL
.	NULL

,	NULL
Rosales	NULL
R.	NULL
,	NULL
Staub	NULL
A.	NULL
and	NULL
Chambon	NULL
P.	NULL
(	NULL
19838	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
931-942	NULL
.	NULL

27	NULL
.	NULL

Mantovani	NULL
R.	NULL
,	NULL
Malgaretti	NULL
N.	NULL
,	NULL
Nicolis	NULL
S.	NULL
,	NULL
Ronchi	NULL
A.	NULL
,	NULL
Giglioni	NULL
B.	NULL
and	NULL
Ottolenghi	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
,	NULL
7783-7797	NULL
.	NULL

28	NULL
.	NULL

Perkins	NULL
N.D.	NULL
,	NULL
Orchard	NULL
K.H	NULL
.	NULL

,	NULL
Collins	NULL
M.L.K	NULL
.	NULL

,	NULL
Latchman	NULL
D.S	NULL
.	NULL

and	NULL
Goodwin	NULL
G.H	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

269	NULL
,	NULL
543-545	NULL
.	NULL

29	NULL
.	NULL

Yamamoto	NULL
M.	NULL
,	NULL
Ko	NULL
L.J	NULL
.	NULL

,	NULL
Leonard	NULL
M.W	NULL
.	NULL

,	NULL
Beug	NULL
H.	NULL
,	NULL
Orkin	NULL
S.H	NULL
.	NULL

and	NULL
Engel	NULL
J.D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1650-1662	NULL
.	NULL

30	NULL
.	NULL

Hannon	NULL
R.	NULL
,	NULL
Evans	NULL
T.	NULL
,	NULL
Felsenfeld	NULL
G.	NULL
and	NULL
Gould	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
88	NULL
,	NULL
3004-3008	NULL
.	NULL

31	NULL
.	NULL

Tsai	NULL
S.-F.	NULL
,	NULL
Strauss	NULL
E.	NULL
and	NULL
Orkin	NULL
S.H	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
919-931	NULL
.	NULL

